Of course, OEMs may capitalise on the growing promise of lung cancer AI by securing value-enhancing partnerships and acquisitions. Identifying which third-party vendors offer the most credible AI products or, indeed, which offer the best expertise to assist the development of in-house software, will propel improvements in scan times, read times, and case prioritisation. The rewards from such strategic maneuvering will thus prove critical in differentiating a vendor from its competition and could create an opportunity to demonstrate superior ROI. In addition, forming partnerships with healthcare charities and other bodies could be a big step toward consolidating brand presence in the "lung screening workhorse" space. With these factors considered, established market players will, on balance, gain the most from the evolving guidelines.
The bottom line
Major national and regional lung cancer screening programmes will be commonplace in Europe 10 years from now. Moreover, the takeoff of European programmes marks a transformative shift for LCS, serving as a catalyst for technological innovation and the introduction of new programmes worldwide. In a sense, the question is no longer whether LCS will accelerate demand for CT equipment but how decisively vendors will take advantage of the coming tide. On this point, rising investment in cutting-edge AI solutions, decisive strategic plays, and LCS-orientated marketing will ultimately determine which vendors establish a commanding position in the space and which are left frustrated on the sidelines.
Ad Statistics
Times Displayed: 49502
Times Visited: 1402 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About the author: Matthew Watson joined Signify Research in 2022 as part of the Medical Imaging team. He holds a first-class MA degree in Economics, graduating from Heriot-Watt University in 2022, and previously worked as an intern at Unilever. Signify Research’s Medical Imaging team formulates expert market intelligence for some of the leading Ultrasound, CT, MRI, and X-ray vendors. Signify Research provides health tech market intelligence powered by data that you can trust. We blend insights collected from in-depth interviews with technology vendors and healthcare professionals with sales data reported to us by leading vendors to provide a complete and balanced view of the market trends. Our coverage areas are Medical Imaging, Clinical Care, Digital Health, Diagnostic and Lifesciences and Healthcare IT.
Back to HCB News
